Disclosures for "Use of Receptor and Non-receptor Tyrosine Kinase Inhibitors Is Associated with Lower Risk of Developing Parkinson Disease "
-
Dr. Malaty has nothing to disclose.
-
The institution of Dr. Nielsen has received research support from National Institutes of Health. The institution of Dr. Nielsen has received research support from Department of Defense. The institution of Dr. Nielsen has received research support from The Michael J. Fox Foundation for Parkinson's Research. The institution of Dr. Nielsen has received research support from Cure AD. The institution of Dr. Nielsen has received research support from Washington University in St. Louis. Dr. Nielsen has received personal compensation in the range of $0-$499 for serving as a Review Committee with The Michael J. Fox Foundation for Parkinson's Research. Dr. Nielsen has received personal compensation in the range of $500-$4,999 for serving as a Review Committee with Parkinson's Foundation.
-
The institution of Dr. Laurido-Soto has received research support from Washington University in St. Louis.
-
Dr. Racette has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for American Regent. Dr. Racette has received personal compensation in the range of $500-$4,999 for serving as a advisory council with NIEHS.